Stanley Druckenmiller's TXG Position Overview
Stanley Druckenmiller (via Duquesne Family Office LLC) currently holds 403,100 shares of 10x Genomics, Inc. (TXG) worth $15.46 M, representing 0.30% of the portfolio. First purchased in 2022-Q3, this short-term holding has been held for 3 quarters.
Based on 13F filings, Stanley Druckenmiller has maintained this position in TXG for several quarters, showing initial confidence in the investment. Largest addition occurred in Q2 2026, adding 403,100 shares. Largest reduction occurred in Q4 2022, reducing 116,715 shares.
Analysis based on 13F filings available since 2013 Q2
Stanley Druckenmiller's 10x Genomics (TXG) Holding Value Over Time
Track share changes against reported price movement
Quarterly 10x Genomics (TXG) Trades by Stanley Druckenmiller
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +403,100 | New Buy | 403,100 | $38.34 |
| Q4 2022 | -116,715 | Sold Out | 0 | $0.00 |
| Q3 2022 | +116,715 | New Buy | 116,715 | $28.48 |
Stanley Druckenmiller's 10x Genomics Investment FAQs
Stanley Druckenmiller first purchased 10x Genomics, Inc. (TXG) in Q3 2022, acquiring 116,715 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Stanley Druckenmiller has held 10x Genomics, Inc. (TXG) for 3 quarters since Q3 2022.
Stanley Druckenmiller's largest addition to 10x Genomics, Inc. (TXG) was in Q2 2026, adding 403,100 shares worth $15.46 M.
According to the latest 13F filing for Q2 2026, Stanley Druckenmiller's firm, Duquesne Family Office LLC, owns 403,100 shares of 10x Genomics, Inc. (TXG), valued at approximately $15.46 M.
As of the Q2 2026 filing, 10x Genomics, Inc. (TXG) represents approximately 0.30% of Stanley Druckenmiller's publicly disclosed stock portfolio, making it one of their key holdings.
Stanley Druckenmiller's peak holding in 10x Genomics, Inc. (TXG) was 403,100 shares, as reported at the end of Q2 2026.